Phase 2 Chronic Heart Failure Clinical Trials
5 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–5 of 5 trials
Recruiting
Phase 1Phase 2
A Phase I/II Clinical Trial of Intramyocardial Injection of HucMSCs for the Treatment of Chronic Heart Failure
Chronic Heart FailureCoronary Artery Bypass Grafting (CABG)Chronic Ischemic Cardiomyopathy
Tasly Pharmaceutical Group Co., Ltd51 enrolled4 locationsNCT07265349
Recruiting
Phase 2Phase 3
Effect of Weight Loss on Physical and Cardiac Performance in People With Obesity and Heart Failure
ObesityWeight LossHeart Failure With Reduced Ejection Fraction+1 more
Jens D Hove, MD,PHD100 enrolled1 locationNCT06423599
Withdrawn
Phase 2
A Phase 2, Open-label, Single-arm Study to Evaluate the Tolerability, Safety, and Pharmacodynamic Effects of KER-012 in Participants with Chronic Heart Failure.
Chronic Heart Failure
Keros Therapeutics, Inc.12 enrolled1 locationACTRN12623001290684
Recruiting
Phase 2
Endocalyx for Heart Failure
Chronic Heart Failure
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)64 enrolled1 locationNCT05966415
Terminated
Phase 2
Iron Infusion in Heart Failure Study
Chronic Heart Failure
Professor Andrew Sindone82 enrolled1 locationACTRN12615000952549